Stephen Eck
2023
In 2023, Stephen Eck earned a total compensation of $1.8M as Senior Vice President, Clinical Development and Chief Medical Officer at MacroGenics.
Compensation breakdown
| Non-Equity Incentive Plan | $231,840 |
|---|---|
| Option Awards | $742,820 |
| Salary | $521,808 |
| Stock Awards | $241,000 |
| Other | $13,200 |
| Total | $1,750,668 |
Eck received $742.8K in option awards, accounting for 42% of the total pay in 2023.
Eck also received $231.8K in non-equity incentive plan, $521.8K in salary, $241K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Stephen Eck's compensation ranked 639th out of 3,006 executives tracked by ExecPay. In other words, Eck earned more than 78.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 639 out of 3,006 | 79th |
Division Manufacturing | 356 out of 1,650 | 78th |
Major group Chemicals And Allied Products | 244 out of 918 | 73rd |
Industry group Drugs | 240 out of 881 | 73rd |
Industry Pharmaceutical Preparations | 154 out of 637 | 76th |
Source: SEC filing on April 8, 2024.
Eck's colleagues
We found two more compensation records of executives who worked with Stephen Eck at MacroGenics in 2023.